Answer
In healthy subjects with wild-type OCT2, vandetanib increased metformin AUC(0–t) by 74% and Cmax by 50% and decreased renal clearance by 52%; appropriate clinical and/or laboratory monitoring is recommended during concomitant treatment, and patients may require a lower metformin dose.
Sources for this answer
- Caprelsa 300 mg film-coated tabletsSANOFI · emc · SmPC §4.5 Interaction with other medicinal products · Version 9Document updated
Sources checked